Applications of nanotechnology for treatment, diagnosis, monitoring, and control of biological systems has recently been referred to as nanomedicine by the National Institutes of Health. Research into the rational delivery and targeting of pharmaceutical, therapeutic, and diagnostic agents is at the forefront of projects in nanomedicine. These involve the identification of precise targets (cells and receptors) related to specific clinical conditions and choice of the appropriate nanocarriers to achieve the required responses while minimizing the side effects. Mononuclear phagocytes, dendritic cells, endothelial cells, and cancers (tumor cells, as well as tumor neovasculature) are key targets.
The articles related to clinical nano medicine are published in journals of OMICS International, which are of high impact factor .These articles are of high quality standards and have numerous citations .These articles is peer reviewed by eminent editorial members . OMICS Group international is an Open Access publisher that publishes about 700+ peer-reviewed journals on a variety of subjects with the team of above 25000 editorial board members. It organizes over 3000+ International Scientific Conferences. The quality manuscripts related to clinical nano medicine is available in OMICS journal of journal of Nano medicine and bio therapeutic discovery.
Last date updated on September, 2024
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi